A minimum of 3 years of sustained clinical remission may protect against an increase in disease activity and the development ...

In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle ...

Researchers identified 4 prepregnancy conditions that were associated with better pregnancy outcomes among patients with SLE.

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect ...

Nkarta is laying off a third of its employees, including half of the biotech’s executive leadership, as the company diverts ...

Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity and remission, and more time spent in those states, vs. standard therapy ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Medicare covers lupus treatment in different ways depending on your age and how the condition affects you. Read more.

A common form of lupus is systemic lupus erythematosus. Systemic lupus erythematosus affects the whole body and can attack virtually any part of it, including skin, major organs, hair, muscles ...